Today: 29 June 2026
Browse Category

NASDAQ:ZYME 17 November 2025

Jazz Pharmaceuticals (JAZZ) Soars on Breakthrough Ziihera Phase 3 Results in Gastroesophageal Cancer – Key Updates for 17 November 2025

Jazz Pharmaceuticals (JAZZ) Soars on Breakthrough Ziihera Phase 3 Results in Gastroesophageal Cancer – Key Updates for 17 November 2025

Jazz Pharmaceuticals plc is in the spotlight today after announcing positive Phase 3 data for its cancer drug Ziihera® in a large global trial for HER2‑positive gastroesophageal adenocarcinoma. The news has triggered sharp pre‑market moves in Jazz’s share price and its partners’ stocks, and could reshape the treatment landscape for a difficult‑to‑treat cancer. PR Newswire+1 As of early afternoon U.S. trading on Monday, November 17, Jazz Pharmaceuticals shares are trading around $141.07, little changed on the day according to real‑time quote data.
17 November 2025
···
Zymeworks (ZYME) Soars on Positive Phase 3 Ziihera Data in Gastric Cancer – What Today’s Breakthrough Means for the Stock and Patients

Zymeworks (ZYME) Soars on Positive Phase 3 Ziihera Data in Gastric Cancer – What Today’s Breakthrough Means for the Stock and Patients

Before the U.S. market open on November 17, 2025, Vancouver‑based Zymeworks Inc. released topline Phase 3 data from its pivotal HERIZON‑GEA‑01 study, evaluating Ziihera in first‑line treatment of HER2‑positive locally advanced or metastatic gastroesophageal adenocarcinoma, a group that includes cancers of the stomach, gastroesophageal junction, and esophagus. GlobeNewswire+1 The trial compared three regimens:
17 November 2025
····

Stock Market Today

  • ASX Penny Stocks: Alligator Energy, Hearts and Minds, Hansen Technologies in Focus
    June 29, 2026, 3:56 PM EDT. Penny stocks on the ASX are grabbing attention as volatility continues. Alligator Energy (ASX:AGE) is still pre-revenue, valued at A$230.73 million, and betting on uranium exploration. The company is running deeper losses but says its cash should last 2.7 years, and analysts see a possible 62.8% jump in shares. Hearts and Minds Investments (ASX:HM1) has a market cap of A$670.92 million. The investment firm's profits are down 84.9%, and its 6.48% dividend yield has investors wondering about longevity. Hansen Technologies sits at a A$904.29 million market cap, pulling in revenue from its Energy & Utilities business. Together, the names show the range of plays and issues in the ASX penny stock scene.
Go toTop